Standard BioTools Inc. Common Stock (LAB) is a publicly traded Healthcare sector company. As of July 22, 2026, LAB trades at $0.84 with a market cap of $332.74M and a P/E ratio of -4.32. LAB moved -4.07% today. Year to date, LAB is -30.93%; over the trailing twelve months it is -29.83%. Its 52-week range spans $0.70 to $2.25. Analyst consensus is neutral with an average price target of $1.35. Rallies surfaces LAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for LAB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.84 |
| Market Cap | $332.74M |
| P/E Ratio | -4.32 |
| EPS | $-0.20 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.25 |
| 52-Week Low | $0.70 |
| Volume | 141.94K |
| Avg Volume | 0 |
| Revenue (TTM) | $85.33M |
| Net Income | $-74.90M |
| Gross Margin | 49.86% |
1 analysts cover LAB: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.35.